| Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer (NCT07687875) | Henry Smith | 2026-06-17 |
| A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD) (NCT07619820) | CSL Behring | 2026-06-17 |
| A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants (NCT07656454) | Novo Nordisk A/S | 2026-06-17 |
| A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy (NCT07564401) | Novartis Pharmaceuticals | 2026-06-16 |
| Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors (NCT07660055) | Novartis Pharmaceuticals | 2026-06-16 |
| IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors (NCT07508761) | Nanjing Immunophage Biotech Co., Ltd | 2026-06-16 |
| A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancer (NCT07550842) | Shanghai Best-Link Bioscience, LLC | 2026-06-16 |
| Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer? (NCT07733505) | Odense University Hospital | 2026-06-16 |
| Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma (NCT07392957) | Washington University School of Medicine | 2026-06-16 |
| First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients (NCT07708116) | Centauri Therapeutics Limited | 2026-06-16 |
| Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer （mCRPC） (NCT07660211) | VitsGen Therapeutics Inc. | 2026-06-16 |
| Adia Med of Winter Park LLC Lower Back Pain Research Study (NCT07587047) | Adia Med of Winter Park LLC | 2026-06-16 |
| A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA) (NCT07606274) | Nuevocor Pte. Ltd. | 2026-06-16 |
| A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA (NCT07604116) | Synusight Biotech (Shanghai) Co., Ltd. | 2026-06-15 |
| Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis (NCT07562074) | University of Calgary | 2026-06-15 |
| A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects (NCT07633691) | Dong-A ST Co., Ltd. | 2026-06-15 |
| Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy (NCT07199413) | Medical College of Wisconsin | 2026-06-15 |
| A Study of CRD3874-SI in People With Leukemia (NCT07661095) | Memorial Sloan Kettering Cancer Center | 2026-06-15 |
| Phase I/II Clinical Study to Evaluate the Safety, Tolerability and Efficacy of LY-M003 Injection in Adult Patients With Wilson's Disease (NCT07641140) | Lingyi Biotech Co., Ltd. | 2026-06-15 |
| The Safety, Tolerability, and Efficacy of Dopaminergic Neural Progenitor Cells (XS411CN Cell Injection) for the Treatment of Multiple System Atrophy Parkinsonian Variant (MSA-P). (NCT07617012) | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 2026-06-15 |
| PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC (NCT07645222) | Hansoh BioMedical R&D Company | 2026-06-15 |
| Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors (NCT07644650) | Mabsoft Therapeutics (Shanghai) Co., Ltd. | 2026-06-15 |
| A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV) (NCT07663838) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-06-15 |
| Evaluation of BRC-002 Safety, Tolerability, Pharmacokinetics, and Food Effects in Healthy Participants (NCT07699120) | Biopharmaceutical Research Company | 2026-06-15 |
| Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL (NCT07638787) | Ruijin Hospital | 2026-06-15 |
| Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine (NCT07683949) | Seoul National University Bundang Hospital | 2026-06-15 |
| Tolerability Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets (NCT07300046) | Aspargo Labs, Inc | 2026-06-15 |
| IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia (NCT07585071) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-15 |
| Study of LGW16-03 To Identify Nerves (NCT07385430) | Eric R. Henderson | 2026-06-15 |
| N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors (NCT07639450) | Hefei Xinzhu Biological Technology Co., Ltd. | 2026-06-15 |
| A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969 (NCT07581431) | InSilico Medicine Hong Kong Limited | 2026-06-15 |
| FES Cycling With BFR in the Spinal Cord Injury Population (NCT07588503) | Dr. B. Catharine. Craven | 2026-06-15 |
| Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis (NCT07567235) | West China Hospital | 2026-06-15 |
| Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants (NCT07673900) | Terrestrial Bio, Inc. | 2026-06-15 |
| Malaria CVD 36000; Gates INV090205 (NCT07558122) | University of Maryland, Baltimore | 2026-06-13 |
| A Study of IN026 in Participants With Refractory Gout (NCT07587684) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-06-12 |
| Chronic CED of TPT for Recurrent Malignant Glioma (NCT06666712) | Jeffrey N. Bruce | 2026-06-12 |
| Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant (NCT06996119) | City of Hope Medical Center | 2026-06-12 |
| A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants (NCT07673601) | argenx | 2026-06-12 |
| A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas (NCT07444619) | M.D. Anderson Cancer Center | 2026-06-12 |
| A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies (NCT07340190) | Novartis Pharmaceuticals | 2026-06-12 |
| A Clinical Study of HRS-7156 in Healthy Participants (NCT07601087) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-12 |
| A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL (NCT07607925) | GlaxoSmithKline | 2026-06-12 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity (NCT07559136) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-06-12 |
| First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults (NCT07646353) | GlaxoSmithKline | 2026-06-12 |
| A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors (NCT07623369) | Huahui Health | 2026-06-11 |
| Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients (NCT07510308) | West China Hospital | 2026-06-11 |
| A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis (NCT07692165) | Innatus Therapeutics (Shanghai) Co., Ltd. | 2026-06-11 |
| Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants (NCT07646548) | Sanofi | 2026-06-11 |
| To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults (NCT07655960) | AJU Pharm Co., Ltd. | 2026-06-11 |
| Sitagliptin in Recurrent/Progressive Grade 4 Glioma (NCT07541781) | Kailin Yang, MD, PhD | 2026-06-11 |
| A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus (NCT07590193) | Amgen | 2026-06-11 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT07606612) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-06-11 |
| Robot-Assisted Hematoma Evacuation With Intrahematoma Tenecteplase for Post-Reperfusion PH2 Hemorrhagic Transformation (NCT07641998) | Beijing Tiantan Hospital | 2026-06-10 |
| A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder (NCT07460947) | Mclean Hospital | 2026-06-10 |
| A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants (NCT07531628) | Boehringer Ingelheim | 2026-06-10 |
| Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects (NCT07697560) | AnHorn Medicines Co. Ltd. | 2026-06-10 |
| A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults (NCT07622433) | AstraZeneca | 2026-06-10 |
| A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in Patients With Tumor Cachexia (NCT07519564) | Kexing Biopharm Co., Ltd. | 2026-06-10 |
| Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA (NCT07620275) | Chinese PLA General Hospital | 2026-06-10 |
| Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (NCT07668557) | iCell Gene Therapeutics | 2026-06-10 |
| Single-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma (NCT07623681) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2026-06-10 |
| ENLIGHT-AML - An Open-label, Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT07084584) | Galecto Biotech AB | 2026-06-10 |
| A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy (NCT07468851) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-06-10 |
| A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia (NCT07012044) | National Cancer Institute (NCI) | 2026-06-09 |
| Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation (NCT07626281) | Novartis Pharmaceuticals | 2026-06-09 |
| A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft Antibody Mediated Rejection (ABMR). (NCT07641426) | CASI pharmaceuticals, Inc. | 2026-06-09 |
| FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers (NCT07638371) | Memorial Sloan Kettering Cancer Center | 2026-06-09 |
| Pharmacokinetics and Safety of Single-Dose Wafermine™ (Ketamine Sublingual Wafer) in Healthy Subjects (NCT07691372) | iX Biopharma Ltd. | 2026-06-09 |
| Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease (NCT07252050) | Arkansas Children's Hospital Research Institute | 2026-06-08 |
| MRG003 With Gemcitabine for Second-line Advanced PDAC (NCT07685470) | Peking Union Medical College Hospital | 2026-06-08 |
| Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments (NCT07468071) | Novartis Pharmaceuticals | 2026-06-08 |
| A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer (NCT07689656) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-06-08 |
| A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer (NCT07401381) | Rovi Pharmaceuticals Laboratories | 2026-06-08 |
| A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants (NCT07608705) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-08 |
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer (NCT07560124) | Akeso | 2026-06-06 |
| Efficacy and Safety of Trifluridine/Tipiracil (TAS-102) Combined With Bevacizumab and Serplulimab in Patients With Metastatic Colorectal Cancer Undergoing Cytoreductive Surgery: A Single-Arm, Single-Center Clinical Study (NCT06882915) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-06-06 |
| Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma (NCT07513129) | M.D. Anderson Cancer Center | 2026-06-05 |
| A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults (NCT07628049) | GlaxoSmithKline | 2026-06-05 |
| QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction (NCT07620041) | Qilu Pharmaceutical Co., Ltd. | 2026-06-05 |
| Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn Management (NCT06362226) | Virginia Commonwealth University | 2026-06-05 |
| hUC-MSC-Exosomes for T2DM - Safety & Efficacy (NCT07693036) | Peking University First Hospital | 2026-06-05 |
| Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors (NCT07567222) | West China Hospital | 2026-06-05 |
| Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors. (NCT07570563) | Chinese PLA General Hospital | 2026-06-05 |
| Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel) (NCT07539090) | Deciphera Pharmaceuticals, LLC | 2026-06-05 |
| A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations (NCT07629960) | Blueprint Medicines Corporation | 2026-06-04 |
| Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury (NCT07236463) | Centre Hospitalier Universitaire de Nīmes | 2026-06-04 |
| DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia (NCT07623525) | Diagonal Therapeutics, Inc. | 2026-06-04 |
| A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants. (NCT07619183) | Prime Gene Therapeutics Co., Ltd. | 2026-06-04 |
| A Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of BGB-58067 in Healthy Participants (NCT07590102) | BeOne Medicines | 2026-06-04 |
| Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 (NCT07636928) | ViiV Healthcare | 2026-06-04 |
| A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants (NCT07466550) | AbbVie | 2026-06-04 |
| A Study to Evaluate ALN-6222 in Participants With Obesity (NCT07624071) | Alnylam Pharmaceuticals | 2026-06-04 |
| Single Ascending Doses (SAD) and Multiple Ascending Doses(MAD) Study of IG001119 in Healthy Adult Participants (NCT07618247) | Iongen Therapeutics Co., Ltd. | 2026-06-04 |
| A Study of HS-10587 in Patients With Advanced Solid Tumors (NCT07567859) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-06-04 |
| Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer (NCT07590934) | AstraZeneca | 2026-06-03 |
| A Study of LY4065967 in Healthy Participants (NCT07607483) | Eli Lilly and Company | 2026-06-03 |
| Phase I Study of HRS-3005 in B-cell Malignancies (NCT07556822) | Jiangsu HengRui Medicine Co., Ltd. | 2026-06-03 |
| Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease (NCT07192900) | David Bartlett, MD | 2026-06-03 |
| aPBI Re-irradiation (NCT07612254) | Dartmouth-Hitchcock Medical Center | 2026-06-03 |